title: Joint ESC/EASD guidelines on diabetes, where are we now and where should we go?
abstract: Patients with diabetes and prediabetes are at high risk for micro- and macrovascular complications. A multifactorial management strategy improves their prognosis considerably. Of concern is that these patients often fall between two specialties: cardiovascular medicine and diabetology. Practice guidelines for this patient category have been issued in collaboration between the European Society of Cardiology and the European Association for the Study of Diabetes to ascertain management according to the best available evidence. This article discusses why and for whom such guidelines are important.
authors.affiliation: Cardiology Unit, Department of Medicine, Karolinska Institutet, Stockholm, Sweden. lars.ryden@ki.se
authors.forename: Lars
authors.initials: L
authors.lastname: Rydén
authors.forename: Linda
authors.initials: L
authors.lastname: Mellbin
mesh_terms: D002317:Cardiovascular Agents / Q000627:therapeutic use*; D002318:Cardiovascular Diseases / Q000175:diagnosis / Q000453:epidemiology / Q000628:therapy*; D048909:Diabetes Complications / Q000175:diagnosis / Q000453:epidemiology / Q000628:therapy*; D003920:Diabetes Mellitus / Q000175:diagnosis / Q000453:epidemiology / Q000628:therapy*; D019317:Evidence-Based Medicine; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D017410:Practice Guidelines as Topic; D011236:Prediabetic State / Q000175:diagnosis / Q000453:epidemiology / Q000628:therapy*; D040242:Risk Reduction Behavior
chemical_list: D002317:Cardiovascular Agents; D007004:Hypoglycemic Agents